The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Opiates Transdeactivate Chemokine Receptors: δ and μ Opiate Receptor–mediated Heterologous Desensitization
Open accessAbstract
An intact chemotactic response is vital for leukocyte trafficking and host defense. Opiates are known to exert a number of immunomodulating effects in vitro and in vivo, and we sought to determine whether they were capable of inhibiting chemokine-induced directional migration of human leukocytes, and if so, to ascertain the mechanism involved. The endogenous opioid met-enkephalin induced monocyte chemotaxis in a pertussis toxin–sensitive manner. Met-enkephalin, as well as morphine, inhibited IL-8–induced chemotaxis of human neutrophils and macrophage inflammatory protein (MIP)-1α, regulated upon activation, normal T expressed and secreted (RANTES), and monocyte chemoattractant protein 1, but not MIP-1β–induced chemotaxis of human monocytes. This inhibition of chemotaxis was mediated by δ and μ but not κ G protein–coupled opiate receptors. Calcium flux induced by chemokines was unaffected by met-enkephalin pretreatment. Unlike other opiate-induced changes in leukocyte function, the inhibition of chemotaxis was not mediated by nitric oxide. Opiates induced phosphorylation of the chemokine receptors CXCR1 and CXCR2, but neither induced internalization of chemokine receptors nor perturbed chemokine binding. Thus, inhibition of chemokine-induced chemotaxis by opiates is due to heterologous desensitization through phosphorylation of chemokine receptors. This may contribute to the defects in host defense seen with opiate abuse and has important implications for immunomodulation induced by several endogenous neuropeptides which act through G protein–coupled receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The syntax of immune-neuroendocrine communication
Blalock, J. E. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90205-4 · Cited by 717 · cited 1×
“However, this study may also have relevance in the potential modulation of immune and inflammatory responses due to endogenous opiate molecules, which among other neuropeptides are known to be released by cells of the immune system (38), and which may act as normal regulators of chemotaxis.”
Background
Cited by
Dancing to the tune of chemokines
Thelen, M. (2001) · Nature Immunology · doi:10.1038/84224 · Cited by 618
Opioids, opioid receptors, and the immune response
McCarthy, L., Wetzel, M., Sliker, J. K., Eisenstein, T. K., & Rogers, T. J. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00181-2 · Cited by 401
Hutchinson, M. R., Shavit, Y., Grace, P. M., Rice, K. C., Maier, S. F., & Watkins, L. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.004135 · Cited by 397
Opioid Therapy and Immunosuppression: A Review
Vallejo, R., de Leon-Casasola, O., & Benyamin, R. (2004) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000132250.95650.85 · Cited by 386
Cytokine and Chemokine Regulation of Sensory Neuron Function
Miller, R. J., Jung, H., Bhangoo, S. K., & White, F. A. (2009) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-79090-7_12 · Cited by 364
Breaking barriers to novel analgesic drug development
Yekkirala, A. S., Roberson, D. P., Bean, B. P., & Woolf, C. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.87 · Cited by 364
Chemokines and the pathophysiology of neuropathic pain
White, F. A., Jung, H., & Miller, R. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709250104 · Cited by 363
Microbial Infections, Immunomodulation, and Drugs of Abuse
Friedman, H., Newton, C., & Klein, T. W. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.2.209-219.2003 · Cited by 338
Current Research on Opioid Receptor Function
Feng, Y., He, X., Yang, Y., Chao, D., H. Lazarus, L., & Xia, Y. (2012) · Current Drug Targets · doi:10.2174/138945012799201612 · Cited by 329
Roy, S., Ninkovic, J., Banerjee, S., Charboneau, R. G., Das, S., Dutta, R., Kirchner, V. A., Koodie, L., Ma, J., Meng, J., et al. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9292-5 · Cited by 309
The role of opioid receptors in immune system function
Eisenstein, T. K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02904 · Cited by 286
Chemokines: Integrators of Pain and Inflammation
White, F. A., Bhangoo, S. K., & Miller, R. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1852 · Cited by 280
Howard, O. M. Z., Dong, H. F., Yang, D., Raben, N., Nagaraju, K., Rosen, A., Casciola-Rosen, L., Härtlein, M., Kron, M., Yang, D., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020186 · Cited by 279
Self-citationChemoattractant Receptor Cross-desensitization
Ali, H., Richardson, R. M., Haribabu, B., & Snyderman, R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6027 · Cited by 269
Self-citationSzabo, I., Chen, X.-H., Xin, L., Adler, M. W., Howard, O. M. Z., Oppenheim, J. J., & Rogers, T. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102327699 · Cited by 255
Self-citationRole of the mu-opioid receptor in opioid modulation of immune function
Ninković, J., & Roy, S. (2013) · Amino Acids · doi:10.1007/s00726-011-1163-0 · Cited by 196
Sacerdote, P., Massi, P., Panerai, A. E., & Parolaro, D. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00307-6 · Cited by 124
Metadata
- Authors
- Grimm, M. C., Ben-Baruch, A., Taub, D. D., Howard, O. M. Z., Resau, J. H., Wang, J. M., Ali, H., Richardson, R., Snyderman, R., & Oppenheim, J. J.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1998-07-20
- Volume
- 188
- Issue
- 2
- Pages
- 317-325
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2035646853
- Cited by
- 212
- References
- 1
- FWCI
- 4.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.